Avestar Capital’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,082
Closed -$352K 525
2024
Q1
$352K Sell
1,082
-910
-46% -$223K 0.04% 304
2023
Q4
$380K Buy
1,992
+1,770
+797% +$335K 0.04% 248
2023
Q3
$44.2K Sell
222
-4
-2% -$946 0.01% 365
2023
Q2
$64.5K Buy
+226
New +$62.8K 0.01% 329
2022
Q3
Sell
-508
Closed -$97K 324
2022
Q2
$97K Sell
508
-1,483
-74% -$262K 0.02% 275
2022
Q1
$413K Buy
+1,991
New +$328K 0.07% 258
2021
Q4
Sell
-5,148
Closed -$1.06M 518
2021
Q3
$1.06M Buy
+5,148
New +$1.01M 0.14% 172

Other funds holding SWAV

Avestar Capital's SWAV Position: Q2 2024 in Review

Avestar Capital sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,082 shares — an estimated $352K sold.

Avestar Capital first reported a position in SWAV in Q3 2021 and held it in 7 quarters. The position peaked at $1.06M in Q3 2021. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Avestar Capital reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Avestar Capital sold 1,082 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $352K.
  • Avestar Capital first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • Avestar Capital's Shockwave Medical, Inc. Common Stock position peaked at $1.06M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Avestar Capital's 13F filing for Q2 2024, filed 8 Aug 2024.